ask="11.30"
ask_size="1000"
average_daily_volume="28116"
bid="3.12"
bid_size="100"
book_value="3.34"
change="+0.87"
change_from_200_day_moving_average="4.14"
change_from_50_day_moving_average="2.82"
change_from_52_week_high="-0.18"
change_From_52_week_low="7.30"
change_in_percent="+8.74%"
close="10.82"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.26"
ebitda="-50.28M"
eps_estimate_current_year="-2.54"
eps_estimate_next_quarter="-0.60"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="N/A"
high="10.99"
high_52_weeks="11.00"
last_trade_date="2/17/2017"
last_trade_price="10.82"
last_trade_size="111"
last_trade_time="4:00pm"
low="10.07"
low_52_weeks="3.52"
market_capitalization="230.25M"
moving_average_200_day="6.68"
moving_average_50_day="8.00"
name="Nabriva Therapeutics AG - Ameri"
notes="N/A"
one_year_target_price="15.83"
open="10.07"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+61.88%"
percent_change_from_50_day_moving_average="+35.29%"
percent_change_from_52_week_high="-1.64%"
percent_change_from_52_week_low="+207.39%"
previous_close="9.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.98"
price_per_sales="40.72"
revenue="5.20M"
shares_outstanding="21280000"
short_ratio="3.79"
stock_exchange="NMS"
symbol="NBRV"
volume="92042"
weeks_range_52="3.52 - 11.00"
